News

Although some clinical activity was observed, the trial did not meet its endpoint for the number of patients with a response to therapy. However, Kosan will continue with

In the 58-patient randomized, double-blind, placebo-controlled clinical trial, conducted at two study centers in the US, the group consisting of 30 subjects who received ALGRX 4975 (100 micrograms)

The Apaf-1 (Apoptosis Protease Activating Factor 1) gene was discovered using large families from Utah that contain multiple cases of major depressive disorder. The evidence presented in the

The study will evaluate the safety of and immune response to AG-707 in up to 84 patients with herpes simplex virus type 2 (HSV-2), an infection affecting one

Tocosol paclitaxel has shown promising safety and anti-tumor activity in phase II clinical trials in a variety of solid tumors, and the product is currently in a phase

In a departure from conventional methods of biological drug discovery, which use mouse antibodies, Epitomics’ unique approach utilizes monoclonal antibodies from rabbits, potentially improving the quality and efficiency

Earlier this year, the company had reported on the favorable pharmacokinetic profile of the drug showing enhanced bioavailability of the Pro-drug PPL-100 (compared to parent drug, PL-100) and

The company will pay a $136 million criminal fine and $567 million to settle civil liabilities. The resolution also ensures that the US Medicaid programs who paid any

The study showed in laboratory models that combination therapy with topotecan and carboplatin is superior to the standard triple-drug therapy using vincristine, carboplatin and etoposide. The new combination